During the recent session, Sanofi ADR (NASDAQ:SNY)’s traded shares were 3.36 million, with the beta value of the company hitting 0.62. At the last check today, the stock’s price was $49.36, reflecting an intraday gain of 5.90% or $2.75. The 52-week high for the SNY share is $57.82, that puts it down -17.14 from that peak though still a striking 13.63% gain since the share price plummeted to a 52-week low of $42.63. The company’s market capitalization is $123.53B, and the average trade volume was 1.94 million shares over the past three months.
Sanofi ADR (NASDAQ:SNY) trade information
Sanofi ADR (SNY) registered a 5.90% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 5.90% in intraday trading to $49.36, hitting a weekly high. The stock’s 5-day price performance is 8.75%, and it has moved by -0.78% in 30 days. Based on these gigs, the overall price performance for the year is -13.68%.
Sanofi ADR (SNY) estimates and forecasts
Statistics show that Sanofi ADR has underperformed its competitors in share price, compared to the industry in which it operates. Sanofi ADR (SNY) shares have gone down -5.68% during the last six months, with a year-to-date growth rate less than the industry average at -6.83% against 3.90. In the rating firms’ projections, revenue will increase 7.50% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 11.1B as predicted by 6 analyst(s). Meanwhile, a consensus of 5 analyst(s) estimates revenue growth to 11.31B by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 11.33B and 11.23B respectively. In this case, analysts expect current quarter sales to shrink by -2.00% and then jump by 0.70% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 2.68%. While earnings are projected to return -6.48% in 2024, the next five years will return 9.00% per annum.
SNY Dividends
Sanofi ADR is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Sanofi ADR is 1.90, with the dividend yield indicating at 3.85 percent, continuing the trend of increasing dividends in recent years.
